Send Message
Home News

company news about 1 Confirmed, 6 Presumptive Monkeypox Cases in US, Government Releasing Vaccines for Exposed

China Hangzhou AllTest Biotech CO.,LTD certification
Customer Reviews
We recently started selling your HCG tests via our Australian partner and have been very impressed with the quality and consistency of the tests. They seem to be superior to our current manufacturer and we also know that you are far more reliable in terms of production times and communication.

—— One customer from Europe

We would like to explore the possibility of switching our HCG tests over to you. We have been reluctant in the past to move everything over to you as it makes us very reliant on you. However, we have always found you to be by far the most reliable of all our Chinese manufacturers and so we feel comfortable strengthening our partnership further

—— One customer from Europe

I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

I'm Online Chat Now
Company News
1 Confirmed, 6 Presumptive Monkeypox Cases in US, Government Releasing Vaccines for Exposed
Latest company news about 1 Confirmed, 6 Presumptive Monkeypox Cases in US, Government Releasing Vaccines for Exposed

With seven people in the U.S. now confirmed or presumed to have monkeypox, officials from the Centers for Disease Control and Prevention say the risk remains low and there's no evidence the virus has evolved to be more transmissible.


The CDC said Monday that the government is in the process of releasing some vaccines from its national stockpile. There is no need to vaccinate the general public against monkeypox, officials said. Rather, those vaccines will be used among a small number people who have been exposed.


Still, CDC officials cautioned that more cases are likely, and the agency is now raising awareness among men who identify as gay or bisexual.


"I think that we need to pay close attention to the communities in which this might be circulating, so that we can communicate effectively with them and help bring this outbreak under control," McQuiston said.


Monkeypox is not a sexually transmitted infection, and anyone can become infected regardless of sexual orientation.


The virus, a less-transmissible cousin of smallpox, is passed through close contact with another person, including hugging, touching or prolonged face-to-face contact.


An early cluster of monkeypox cases in London was among a nuclear family who lived in the same household.


MORE: Florida health officials investigating 3rd possible monkeypox case in US

But health officials say many early clusters in Europe and Canada happened among groups of men who have sex with men, with some ongoing transmission reported in this community.


"Anyone -- anyone can develop and spread monkeypox infection," Dr. John Brooks, medical epidemiologist, Division of HIV/AIDS Prevention at the CDC, said. "But, many of those affected in the current global outbreak identify as gay and bisexual men. We want to help people make the best-informed decisions to protect their health."


Specifically, the CDC is now warning people to watch out for a distinctive rash in the genital region, which could be confused with an STI.

Pub Time : 2022-05-24 13:06:21 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: 86-13989889852

Send your inquiry directly to us (0 / 3000)